InvestSMART

Telix Pharmaceuticals Limited (ASX: TLX) - Announcements

Current share price for TLX : $16.730 0.63 (3.63%)+

ASX company news and announcements for Telix Pharmaceuticals Limited (TLX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Telix Pharmaceuticals Limited (TLX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Telix Pharmaceuticals Limited (TLX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Telix Pharmaceuticals Limited (TLX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$5,685 S&P DJI Announces June 2020 Quarterly Rebalance 12 Jun 2020 8:16AM $1.310 $16.730 risen by 1,177.10%
$5,685 Update on New Drug Application for Prostate Cancer Imaging 10 Jun 2020 8:25AM $1.415 $16.730 risen by 1,082.33%
$5,685 Presentation to Jefferies Virtual Healthcare Conference 4 Jun 2020 8:26AM $1.345 $16.730 risen by 1,143.87%
$5,685 Appointment of Dr Colin Hayward as Chief Medical Officer 2 Jun 2020 8:19AM $1.385 $16.730 risen by 1,107.94%
$5,685 Appendix 2A - shares issued on exercise of options 1 Jun 2020 8:28AM $1.375 $16.730 risen by 1,116.73%
$5,685 Telix and Pharmalogic US Distribution Agreement 15 May 2020 8:36AM $1.365 $16.730 risen by 1,125.64%
$5,685 Appendix 2A - issues of shares on exercise of options 15 May 2020 8:20AM $1.365 $16.730 risen by 1,125.64%
$5,685 July Pre-IND Meeting with US FDA for Ph III ProstACT Study 14 May 2020 8:41AM $1.405 $16.730 risen by 1,090.75%
$5,685 App 3Y Change in Director Interests - C Behrenbruch 12 May 2020 4:22PM $1.470 $16.730 risen by 1,038.10%
$5,685 Appendix 3G - issue of unlisted Share Options following AGM 12 May 2020 4:20PM $1.470 $16.730 risen by 1,038.10%
$5,685 AGM - Results of Meeting 12 May 2020 2:26PM $1.460 $16.730 risen by 1,045.89%
$5,685 CEO's Address to Annual General Meeting 12 May 2020 8:22AM $1.500 $16.730 risen by 1,015.33%
$5,685 Chairman's Address to Annual General Meeting 12 May 2020 8:21AM $1.500 $16.730 risen by 1,015.33%
$5,685 Submission of European Marketing Authorisation Application 1 May 2020 8:13AM $1.375 $16.730 risen by 1,116.73%
$5,685 Cover note to Seneffe Facility - Shareholder Walkthrough 28 Apr 2020 11:20AM $1.165 $16.730 risen by 1,336.05%
$5,685 Seneffe Manufacturing Facility - Shareholder Walkthrough 28 Apr 2020 8:28AM $1.125 $16.730 risen by 1,387.11%
$5,685 Telix enters exclusive licence with Osaka University 27 Apr 2020 8:22AM $1.100 $16.730 risen by 1,420.91%
$5,685 Investor conference call - transcript of CEO presentation 22 Apr 2020 9:21AM $1.150 $16.730 risen by 1,354.78%
$5,685 Quarterly Shareholder Update 22 Apr 2020 8:19AM $1.150 $16.730 risen by 1,354.78%
$5,685 Appendix 4C and Activity Report March 2020 quarter 21 Apr 2020 8:23AM $1.195 $16.730 risen by 1,300%
$5,685 AGM Notice of Meeting 9 Apr 2020 2:55PM $1.200 $16.730 risen by 1,294.17%
$5,685 Commercial Distribution Agmt for Prostate Cancer Diagnostic 8 Apr 2020 9:54AM $1.215 $16.730 risen by 1,276.95%
$5,685 Telix completes acquisition of licensed production facility 3 Apr 2020 8:26AM $1.110 $16.730 risen by 1,407.21%
$5,685 Telix and partners receive 500k CRC research grant 16 Mar 2020 8:51AM $1.130 $16.730 risen by 1,380.53%
$5,685 Business Update - COVID-19 13 Mar 2020 3:43PM $1.080 $16.730 risen by 1,449.07%

726 - 750 of 948 results

Page 30 of 38

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.